BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8230122)

  • 1. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
    Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Kingsbury WD
    J Med Chem; 1993 Oct; 36(22):3321-32. PubMed ID: 8230122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisubstituted benzene leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
    Konno M; Nakae T; Sakuyama S; Odagaki Y; Nakai H; Hamanaka N
    Bioorg Med Chem; 1997 Aug; 5(8):1649-74. PubMed ID: 9313868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
    Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
    J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
    J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
    Daines RA; Chambers PA; Foley JJ; Griswold DE; Kingsbury WD; Martin LD; Schmidt DB; Sham KK; Sarau HM
    J Med Chem; 1996 Sep; 39(19):3837-41. PubMed ID: 8809171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Tzimas MN; Martin LD; Daines RA; Chambers PA; Kingsbury WD; Griswold DE
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():275-7. PubMed ID: 7732852
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.
    Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity.
    Nakayama Y; Senokuchi K; Sakaki K; Kato M; Maruyama T; Miyazaki T; Ito H; Nakai H; Kawamura M
    Bioorg Med Chem; 1997 May; 5(5):971-85. PubMed ID: 9208106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analogues.
    Boehm JC; Gleason JG; Pendrak I; Sarau HM; Schmidt DB; Foley JJ; Kingsbury WD
    J Med Chem; 1993 Oct; 36(22):3333-40. PubMed ID: 8230123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of structural analogues of leukotriene B4 and their receptor binding activity.
    Konno M; Nakae T; Sakuyama S; Nishizaki M; Odagaki Y; Nakai H; Hamanaka N
    Bioorg Med Chem; 1997 Aug; 5(8):1621-47. PubMed ID: 9313867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of new 1, 3-disubstituted cyclohexanes as structurally rigid leukotriene B(4) receptor antagonists.
    Poudrel JM; Hullot P; Vidal JP; Girard JP; Rossi JC; Muller A; Bonne C; Bezuglov V; Serkov I; Renard P; Pfeiffer B
    J Med Chem; 1999 Dec; 42(26):5289-310. PubMed ID: 10639274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
    Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
    J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leukotriene B
    Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
    Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain.
    Gapinski DM; Mallett BE; Froelich LL; Jackson WT
    J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships.
    Huang FC; Chan WK; Moriarty KJ; Poli G; Morrissette MM; Galemmo RA; Warus JD; Dankulich WP; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3748-55. PubMed ID: 8809163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
    Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.